ALZHEIMER DISEASE, EARLY ONSET
Clinical trials for ALZHEIMER DISEASE, EARLY ONSET explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE, EARLY ONSET trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, EARLY ONSET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can daily light and sound slow Alzheimer's? major trial seeks answers
Disease control OngoingThis study is testing whether a daily treatment using special light and sound stimulation can slow the progression of Alzheimer's disease. About 670 people with mild to moderate Alzheimer's will use either the active stimulation device or a look-alike sham device at home for a ye…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New Alzheimer's drug enters human testing
Disease control OngoingThis early-stage study is testing a new drug called PMN310 in people with early Alzheimer's disease. The main goals are to check if the drug is safe and how the body processes it. Researchers will also look for early signs that it might help slow the disease by measuring certain …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: ProMis Neurosciences, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists map Alzheimer's proteins in the brain over time
Knowledge-focused OngoingThis study aims to better understand how two proteins, amyloid and tau, build up in the brains of people with different forms of Alzheimer's disease. Researchers will use brain scans to track 60 participants with typical or unusual Alzheimer's symptoms over one year. The goal is …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC